Novel Haloacethydrazides as AEP Inhibitors for Treating Alzheimer's Disease.
Rachel MataAnika R SabnisPublished in: ACS medicinal chemistry letters (2023)
Provided herein are novel haloacethydrazides as AEP inhibitors, pharmaceutical compositions, use of such compounds in treating Alzheimer's disease, and processes for preparing such compounds.